ViiV Healthcare HIV Presentation Goldman Sachs 2016

ViiV Healthcare, a joint venture focused exclusively on HIV treatment, presented its ambitious vision to become the leading HIV company by sales, innovation, and reputation. The presentation covered the company's history as a GSK-Pfizer partnership launched in 2009, its unique biotech-within-pharma operating model, and the strategic role of dolutegravir in driving future growth and transforming patient outcomes.